Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2025-12-25 @ 1:38 AM
NCT ID:
NCT02053194
Eligibility Criteria:
Inclusion Criteria:
* Men and women 65 years of age and older (no upper age limit)
* Individuals for whom prescription claims derive from only one pharmacy identifier
* Chronic consumption (\> 3 month claims) of one of the target inappropriate prescriptions. (benzodiazepine/non benzodiazepine hypnotic, long-acting sulfonylurea oral hypoglycemic agents, anticholinergic agents (in the form of first-generation antihistamines) or Nonsteroidal anti-inflammatory drugs \[NSAIDs\] )
* Patients who are willing to participate in the study.
Exclusion Criteria:
* A probable diagnosis of dementia (persons without the capacity to provide informed consent), as determined by a) a prescription for memantine or a cholinesterase inhibitor; b) report from a caregiver or family-member; or c) a baseline screening score on the Folstein Mini-Mental State Exam \< 24
* Inability to understand and or communicate in English and/or French
* Patients living in a long-term care facility
* Concomitant use of any antipsychotic medication
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT02053194
Study Brief:
Protocol Section:
NCT02053194